These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38369348)

  • 1. Importance of B-Type Natriuretic Peptide in the Detection of Patients With Structural Heart Disease in a Primary Care Setting.
    Fujimoto W; Odajima S; Okamoto H; Iwasaki M; Nagao M; Konishi A; Shinohara M; Toh R; Okuda M; Hirata KI; Tanaka H
    Circ J; 2024 Apr; 88(5):732-739. PubMed ID: 38369348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.
    York MK; Gupta DK; Reynolds CF; Farber-Eger E; Wells QS; Bachmann KN; Xu M; Harrell FE; Wang TJ
    J Am Coll Cardiol; 2018 May; 71(19):2079-2088. PubMed ID: 29747827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
    Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
    Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
    Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
    Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Stages of Heart Failure in Primary Care: A Population-Based Study.
    Jorge AL; Rosa ML; Martins WA; Correia DM; Fernandes LC; Costa JA; Moscavitch SD; Jorge BA; Mesquita ET
    J Card Fail; 2016 Feb; 22(2):153-7. PubMed ID: 26547013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
    Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
    El-Saed A; Voigt A; Shalaby A
    Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Hoes AW; van Veldhuisen DJ
    Am Heart J; 2006 May; 151(5):1012.e1-5. PubMed ID: 16644323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.
    Tan ESJ; Chan SP; Liew OW; Chong JPC; Gerard Leong KT; Daniel Yeo PS; Ong HY; Jaufeerally F; Sim D; Ling LH; Lam CSP; Richards AM
    JACC Heart Fail; 2024 Mar; 12(3):461-474. PubMed ID: 37897459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive capacity of the brain natriuretic peptide in the screening of heart failure in a high altitude population.
    Calderón-Gerstein W; Bruno-Huamán A; Damián-Mucha M; Huayllani-Flores L
    Respir Physiol Neurobiol; 2021 Jul; 289():103654. PubMed ID: 33746081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
    Ledwidge M; Gallagher J; Conlon C; Tallon E; O'Connell E; Dawkins I; Watson C; O'Hanlon R; Bermingham M; Patle A; Badabhagni MR; Murtagh G; Voon V; Tilson L; Barry M; McDonald L; Maurer B; McDonald K
    JAMA; 2013 Jul; 310(1):66-74. PubMed ID: 23821090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.
    Fuat A; Murphy JJ; Hungin AP; Curry J; Mehrzad AA; Hetherington A; Johnston JI; Smellie WS; Duffy V; Cawley P
    Br J Gen Pract; 2006 May; 56(526):327-33. PubMed ID: 16638247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.
    Wright SP; Doughty RN; Pearl A; Gamble GD; Whalley GA; Walsh HJ; Gordon G; Bagg W; Oxenham H; Yandle T; Richards M; Sharpe N
    J Am Coll Cardiol; 2003 Nov; 42(10):1793-800. PubMed ID: 14642690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.
    Jan A; Murphy NF; O'Loughlin C; Ledwidge M; McDonald K
    Ir J Med Sci; 2011 Jun; 180(2):355-62. PubMed ID: 21369749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.